(VIANEWS) – The NASDAQ ended the session with Viking Therapeutics (VKTX) rising 5.97% to $4.63 on Tuesday while NASDAQ Composite rose 0.88% to $15,520.79.
Today’s last reported volume for Viking Therapeutics is 457995, 33.95% below its average volume of 693442.
Viking Therapeutics’s last close was $4.88, 51.64% under its 52-week high of $10.09.
The company’s growth estimates for the current quarter and the next is a negative 61.5% and a negative 46.7%, respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Viking Therapeutics’s stock is considered to be overbought (>=80).
Viking Therapeutics’s Stock Yearly Top and Bottom Value
Viking Therapeutics’s stock is valued at $4.63 at 16:34 EST, under its 52-week low of $4.81.
Viking Therapeutics’s Moving Average
Viking Therapeutics’s worth is way under its 50-day moving average of $5.82 and way below its 200-day moving average of $6.03.
More news about Viking Therapeutics (VKTX).